Tex10 is upregulated and promotes cancer stem cell properties and chemoresistance in hepatocellular carcinoma

References

• Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003 Dec 6;362(9399):1907–1917. PubMed PMID: 14667750.
   PubMed Web of Science ®Google Scholar
• Chen W. Cancer statistics: updated cancer burden in China. Chin J Cancer Res. 2015 Feb;27(1):1. PubMed PMID: 25717219; PubMed Central PMCID: PMCPMC4329178.
   PubMed Web of Science ®Google Scholar
• Villanueva A, Minguez B, Forner A, et al. Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy. Annu Rev Med. 2010;61:317–328. PubMed PMID: 20059340; PubMed Central PMCID: PMCPMC3677155.
   PubMed Web of Science ®Google Scholar
• El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011 Sep 22;365(12):1118–1127. PubMed PMID: 21992124.
   PubMed Web of Science ®Google Scholar
• Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001 Nov 1;414(6859):105–111. PubMed PMID: 11689955.
   PubMed Web of Science ®Google Scholar
• Valent P, Bonnet D, De Maria R, et al. Cancer stem cell definitions and terminology: the devil is in the details. Nat Rev Cancer. 2012 Nov;12(11):767–775. PubMed PMID: 23051844.
   PubMed Web of Science ®Google Scholar
• Magee JA, Piskounova E, Morrison SJ. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell. 2012 Mar 20;21(3):283–296. PubMed PMID: 22439924; PubMed Central PMCID: PMCPMC4504432.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Li X, Ding J. Characteristics of liver cancer stem cells and clinical correlations. Cancer Lett. 2016 Sep 1;379(2):230–238. PubMed PMID: 26272183.
   PubMed Web of Science ®Google Scholar
• Fanis P, Gillemans N, Aghajanirefah A, et al. Five friends of methylated chromatin target of protein-arginine-methyltransferase[prmt]-1 (chtop), a complex linking arginine methylation to desumoylation. Mol Cell Proteomics. 2012 Nov;11(11):1263–1273. PubMed PMID: 22872859; PubMed Central PMCID: PMCPMC3494204.
   PubMed Web of Science ®Google Scholar
• Castle CD, Cassimere EK, Denicourt C. LAS1L interacts with the mammalian Rix1 complex to regulate ribosome biogenesis. Mol Biol Cell. 2012 Feb;23(4):716–728. PubMed PMID: 22190735; PubMed Central PMCID: PMCPMC3279398.
   PubMed Web of Science ®Google Scholar
• Ding J, Huang X, Shao N, et al. Tex10 Coordinates epigenetic control of super-enhancer activity in pluripotency and reprogramming. Cell Stem Cell. 2015 Jun 4;16(6):653–668. PubMed PMID: 25936917; PubMed Central PMCID: PMCPMC4458159.
   PubMed Web of Science ®Google Scholar
• Jeter CR, Yang T, Wang J, et al. Concise review: NANOG in cancer stem cells and tumor development: an update and outstanding questions. Stem Cells. 2015 Aug;33(8):2381–2390. PubMed PMID: 25821200; PubMed Central PMCID: PMCPMC4509798.
   PubMed Web of Science ®Google Scholar
• Villodre ES, Kipper FC, Pereira MB, et al. Roles of OCT4 in tumorigenesis, cancer therapy resistance and prognosis. Cancer Treat Rev. 2016 Dec;51:1–9. PubMed PMID: 27788386.
   PubMed Web of Science ®Google Scholar
• Murakami S, Ninomiya W, Sakamoto E, et al. SRY and OCT4 Are required for the acquisition of cancer stem cell-like properties and are potential differentiation therapy targets. Stem Cells. 2015 Sep;33(9):2652–2663. PubMed PMID: 26013162.
   PubMed Web of Science ®Google Scholar
• Lee TK, Castilho A, Cheung VC, et al. CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell Stem Cell. 2011 Jul 8;9(1):50–63. PubMed PMID: 21726833.
   PubMed Web of Science ®Google Scholar
• Zhu P, Wang Y, Du Y, et al. C8orf4 negatively regulates self-renewal of liver cancer stem cells via suppression of NOTCH2 signalling. Nat Commun. 2015 May 19;6:7122. PubMed PMID: 25985737; PubMed Central PMCID: PMCPMC4479000.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Hao X, Yan M, et al. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma. Int J Cancer. 2010 May 1;126(9):2067–2078. PubMed PMID: 19711346.
   PubMed Web of Science ®Google Scholar
• Yin X, Zhang BH, Zheng SS, et al. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling. J Hematol Oncol. 2015 Mar 11;8:23. PubMed PMID: 25879771; PubMed Central PMCID: PMCPMC4377043.
   PubMed Web of Science ®Google Scholar
• Thiagarajan PS, Zheng Q, Bhagrath M, et al. STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance. Endocr Relat Cancer. 2017 Aug;24(8):415–426. PubMed PMID: 28729467; PubMed Central PMCID: PMCPMC5551450.
   PubMed Web of Science ®Google Scholar
• Gentilella A, Kozma SC, Thomas G. A liaison between mTOR signaling, ribosome biogenesis and cancer. Biochim Biophys Acta. 2015 Jul;1849(7):812–820. PubMed PMID: 25735853; PubMed Central PMCID: PMCPMC4766360.
   PubMed Web of Science ®Google Scholar
• Penzo M, Casoli L, Pollutri D, et al. JHDM1B expression regulates ribosome biogenesis and cancer cell growth in a p53 dependent manner. Int J Cancer. 2015 Mar 1;136(5):E272–81. PubMed PMID: 25273595.
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu G, Qiu J, et al. E2F1-regulated long non-coding RNA RAD51-AS1 promotes cell cycle progression, inhibits apoptosis and predicts poor prognosis in epithelial ovarian cancer. Sci Rep. 2017 Jun 30; 7(1):4469. PubMed PMID: 28667302; PubMed Central PMCID: PMCPMC5493660.
   PubMedGoogle Scholar
• Alonso-Lecue P, De Pedro I, Coulon V, et al. Inefficient differentiation response to cell cycle stress leads to genomic instability and malignant progression of squamous carcinoma cells. Cell Death Dis. 2017 Jun 29;8(6):e2901. PubMed PMID: 28661481; PubMed Central PMCID: PMCPMC5520915.
   PubMedGoogle Scholar
• Chiou GY, Yang TW, Huang CC, et al. Musashi-1 promotes a cancer stem cell lineage and chemoresistance in colorectal cancer cells. Sci Rep. 2017 May 19;7(1):2172. PubMed PMID: 28526879; PubMed Central PMCID: PMCPMC5438397.
   PubMedGoogle Scholar
• Xiang D, Cheng Z, Liu H, et al. Shp2 promotes liver cancer stem cell expansion by augmenting beta-catenin signaling and predicts chemotherapeutic response of patients. Hepatology. 2017 May;65(5):1566–1580. PubMed PMID: 28059452.
   PubMed Web of Science ®Google Scholar
• Jiang C, Long J, Liu B, et al. miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma. J Exp Clin Cancer Res. 2017 Jul 27;36(1):99. 10.1186/s13046-017-0568-3. PubMed PMID: 28750679; PubMed Central PMCID: PMCPMC5532790.
   PubMedGoogle Scholar
• Wang X, Li Y, Dai Y, et al. Sulforaphane improves chemotherapy efficacy by targeting cancer stem cell-like properties via the miR-124/IL-6R/STAT3 axis. Sci Rep. 2016 Nov 8;6:36796. PubMed PMID: 27824145; PubMed Central PMCID: PMCPMC5099878.
   PubMed Web of Science ®Google Scholar
• Huang W, Chen Z, Shang X, et al. Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1. Hepatology. 2015 Jun;61(6):1920–1933. PubMed PMID: 25704764.
   PubMed Web of Science ®Google Scholar
• Xiang X, Deng L, Zhang J, et al. A distinct expression pattern of cyclin K in mammalian testes suggests a functional role in spermatogenesis. PLoS One. 2014;9(7):e101539. PubMed PMID: 25004108; PubMed Central PMCID: PMCPMC4086901.
   PubMed Web of Science ®Google Scholar